ACADIAN ASSET MANAGEMENT LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2022$74
-99.9%
129,212
+212.9%
0.00%
-100.0%
Q2 2021$144,000
+65.5%
41,300
+158.8%
0.00%
Q3 2019$87,000
-70.9%
15,956
-36.5%
0.00%
-100.0%
Q2 2019$299,000
+464.2%
25,143
+148.4%
0.00%
Q1 2019$53,000
-81.9%
10,122
-80.0%
0.00%
-100.0%
Q1 2018$293,00050,6030.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders